MedTrace Logo

Clinical Trial to Evaluate EuHZV in Healthy Adults Aged 50 to 69 Years

NCT06409494 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2025-06-17

No results posted yet for this study

Summary

Phase 1 clinical trial to evaluate the safety of HZV-1 and HZV-2 vaccines in healthy adults aged 50 to 69 years who have voluntarily given written consent to participate in this study.

Conditions

  • Varicella Zoster Virus Infection
  • Herpes Zoster

Interventions

BIOLOGICAL

EuHZV

Drug(injection)

BIOLOGICAL

Shingrix

Drug(injection)

Sponsors & Collaborators

  • EuBiologics Co.,Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-15
Primary Completion
2025-07-31
Completion
2026-05-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06409494 on ClinicalTrials.gov